Correlation Between Satsuma Pharmaceuticals and Algorand

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Satsuma Pharmaceuticals and Algorand at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Satsuma Pharmaceuticals and Algorand into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Satsuma Pharmaceuticals and Algorand, you can compare the effects of market volatilities on Satsuma Pharmaceuticals and Algorand and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Satsuma Pharmaceuticals with a short position of Algorand. Check out your portfolio center. Please also check ongoing floating volatility patterns of Satsuma Pharmaceuticals and Algorand.

Diversification Opportunities for Satsuma Pharmaceuticals and Algorand

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Satsuma and Algorand is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Satsuma Pharmaceuticals and Algorand in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algorand and Satsuma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Satsuma Pharmaceuticals are associated (or correlated) with Algorand. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algorand has no effect on the direction of Satsuma Pharmaceuticals i.e., Satsuma Pharmaceuticals and Algorand go up and down completely randomly.

Pair Corralation between Satsuma Pharmaceuticals and Algorand

Given the investment horizon of 90 days Satsuma Pharmaceuticals is expected to under-perform the Algorand. In addition to that, Satsuma Pharmaceuticals is 1.83 times more volatile than Algorand. It trades about -0.23 of its total potential returns per unit of risk. Algorand is currently generating about -0.11 per unit of volatility. If you would invest  34.00  in Algorand on August 29, 2022 and sell it today you would lose (10.00)  from holding Algorand or give up 29.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Satsuma Pharmaceuticals  vs.  Algorand

 Performance (%) 
       Timeline  
Satsuma Pharmaceuticals 
Satsuma Performance
0 of 100
Over the last 90 days Satsuma Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2022. The current disturbance may also be a sign of long term up-swing for the company investors.

Satsuma Price Channel

Algorand 
Algorand Performance
0 of 100
Over the last 90 days Algorand has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Algorand is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Algorand Price Channel

Satsuma Pharmaceuticals and Algorand Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Satsuma Pharmaceuticals and Algorand

The main advantage of trading using opposite Satsuma Pharmaceuticals and Algorand positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Satsuma Pharmaceuticals position performs unexpectedly, Algorand can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algorand will offset losses from the drop in Algorand's long position.
Satsuma Pharmaceuticals vs. Regeneron Pharmaceuticals
Satsuma Pharmaceuticals vs. Vertex Pharmaceutic
The idea behind Satsuma Pharmaceuticals and Algorand pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Algorand vs. Ethereum
Algorand vs. XRP
Algorand vs. Solana
Algorand vs. Cardano
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go